Oncology Therapy Market is expected to hit US$ 440.26 billion by 2033 | Major Companies - Amgen Inc., AstraZeneca, Bayer AG, Merck & Co., Inc., Novartis AG

Market Size and Growth:

The Global Oncology Therapy Market size reached US$ 193.98 billion in 2024 and is expected to reach US$ 440.26 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025-2033.

DataM Intelligence has published a new research report on "Oncology Therapy Market Size 2026". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/oncology-therapy-market?sz

The Oncology Therapy Market refers to the global industry focused on the research, development, production, and commercialization of treatments for cancer. It includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and radiation-based drugs used to manage and cure various malignancies. The market covers branded and generic medications, biologics, and advanced precision therapies delivered through hospitals, specialty clinics, and research centers. Growth is driven by rising cancer prevalence, technological innovation, clinical advancements, and increasing healthcare investments worldwide.

Recent Key Developments of United States:

✅ January 2026: The FDA issued key designations for oncology drugs targeting lung, pancreatic, and blood cancers, advancing precision medicine with RAS inhibitors and cell therapies for rare malignancies. Gotistobart received orphan drug designation for squamous non-small cell lung cancer based on phase 3 data.

✅ November 2025: FDA granted full approval to tarlatamab (Imdelltra) for advanced small cell lung cancer post-platinum chemotherapy, based on MSK-led trials showing efficacy in targeted immunotherapy. Epcoritamab, a T-cell-engaging bispecific antibody, was also approved for lymphoma on November 18.

✅ November 2025: The FDA approved durvalumab for gastric cancers and pembrolizumab combined with enfortumab vedotin for bladder cancer, expanding immunotherapy and antibody-drug conjugate options. These approvals introduced new biosimilars and companion diagnostics to improve precision treatment access.

Recent Key Developments of Japan:

✅ January 2026: Japan's MHLW approved tafasitamab plus rituximab and lenalidomide for relapsed/refractory follicular lymphoma, supported by inMIND trial data showing improved progression-free survival of 22.4 months versus 13.9 months.​

✅ January 2026: Astellas submitted a supplemental new drug application for Padcev (enfortumab vedotin) in Japan, following its US FDA approval in November 2025 for advanced bladder cancer combinations.

✅ November 2025: NEXT Oncology partnered with Kansai Medical University to expand Phase I cancer trials in Japan, enhancing access to innovative therapies under Dr. Toshio Shimizu.​​

List of the Key Players in the Oncology Therapy Market:

Amgen Inc.
AstraZeneca
Bayer AG
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
F. Hoffmann-La Roche Ltd
Novartis AG
GSK plc
Eli Lilly and Company
Rigel Pharmaceuticals, Inc.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/oncology-therapy-market?sz

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Segments Covered in the Oncology Therapy Market:

By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Radiation Therapy, Others.

By Application: Breast Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, Liver Cancer, Esophageal Cancer, Cervical Cancer, Ovarian Cancer, Bladder Cancer, Head and Neck Cancer, Skin Cancer (Melanoma), Pancreatic Cancer, Kidney Cancer, Others.

By End-User: Hospitals, Cancer Research Centers, Specialty Clinics, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=oncology-therapy-market

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Oncology Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Oncology Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Oncology Therapy Market in 2026?
◆ What is the projected growth rate of the Oncology Therapy Market through 2034?
◆ Who are the key players in the Oncology Therapy Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.